Walgreens Boots Alliance, Inc. (WBA) Analysts See $1.55 EPS

March 19, 2018 - By Marguerite Chambers

 Walgreens Boots Alliance, Inc. (WBA) Analysts See $1.55 EPS

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54B giving it 10.90 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock increased 0.28% or $0.19 during the last trading session, reaching $67.57. About 10.31M shares traded or 86.29% up from the average. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 19, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with “Buy” on Thursday, November 2. Mizuho maintained it with “Buy” rating and $87.0 target in Wednesday, January 24 report. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Tuesday, October 24 by Mizuho. The firm earned “Buy” rating on Monday, July 17 by Needham. Robert W. Baird maintained it with “Buy” rating and $82.0 target in Thursday, January 4 report. The rating was upgraded by RBC Capital Markets on Wednesday, October 28 to “Buy”. UBS maintained the shares of WBA in report on Wednesday, August 23 with “Buy” rating. The company was downgraded on Friday, October 6 by Morgan Stanley. The rating was downgraded by Wood to “Underperform” on Friday, July 22. On Monday, October 17 the stock rating was upgraded by Jefferies to “Buy”.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $66.94 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.64 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.